Antibiotice Ia (ATB) — Net Asset Quality Index
Antibiotice Ia (ATB) has a Net Asset Quality Index of 59.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RON1.55 Billion minus total liabilities of RON623.78 Million yields net assets of RON930.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Antibiotice Ia to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Antibiotice Ia Net Asset Quality Index Over Time (2020–2025)
This chart shows how Antibiotice Ia's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the index stands at 59.9%, representing net assets of RON930.75 Million against total assets of RON1.55 Billion RON. See ATB total equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Antibiotice Ia (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Antibiotice Ia from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Antibiotice Ia.
| Year | Quality Index | Net Assets (RON) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.9% | RON932.07 Million | RON1.39 Billion | RON460.49 Million | ▼ -3.0 pp |
| 2024 | 69.9% | RON894.31 Million | RON1.28 Billion | RON384.95 Million | ▼ -4.4 pp |
| 2023 | 74.3% | RON846.96 Million | RON1.14 Billion | RON292.21 Million | ▼ -0.5 pp |
| 2022 | 74.9% | RON641.43 Million | RON856.47 Million | RON215.04 Million | ▲ +7.3 pp |
| 2021 | 67.6% | RON604.99 Million | RON895.39 Million | RON290.40 Million | ▲ +0.7 pp |
| 2020 | 66.9% | RON577.27 Million | RON863.00 Million | RON285.73 Million | — |